scholarly journals Incidence of allergic conjunctivitis in patients with allergic rhinitis: A randomized observational study

Author(s):  
Nameirakpam Devakanta Singh ◽  
Yumnam Tomba Singh ◽  
Takhellambam Biram Singh
AYUSHDHARA ◽  
2020 ◽  
pp. 2636-2642
Author(s):  
Manisha Rajput ◽  
Sukhdev Singh ◽  
Sanjeev Kumar Sharma ◽  
Yogitha Bali M.R

Background: Inflammation of the conjunctiva due to allergy is known as allergic conjunctiva. It is also seen in the people suffering from allergic rhinitis and is affected by all age groups at least once in their lifetime. But older population and children are more prone for allergic conjunctivitis. Objectives: To evaluate the effect of Aschyotana karma or the therapy with Bilvadi eye drops in the management of Vataja abhishyanda (allergic conjunctivitis). Design: This was an observational study with random sampling. Forty subjects who fulfilled the eligibility criteria were included for the study. Patients with complaints of Allergic Conjunctivitis were selected from OPD of Department of Shalakya Tantra (Netra-Roga), R.G.G.P.G. Ayu. Hospital Paprola, Himachal Pradesh. These patients were administered Bilvadi aschyotana 2 eye drops 4to 5 times for 15 days and were assessed for itching, redness, burning sensation and photophobia before the treatment, on the 3rd day, once in a week and after the treatment.  Results: Aschyotana with Bilvadi eye drops in Vataja abhishyanda provided significant relief in itching 70.09%, redness 41.7%, burning sensation 47.6% and photophobia 53.3%.  


Author(s):  
Sucheta Gupta ◽  
Vinod Gupta

Background: Allergic conjunctivitis (AC) accounts for 15% of eye related consultations in primary care centers. AC is commonly manifesting as itchy or watering or red eye, comprising the symptoms of the total ocular symptom scores (TOSS). Recognition of AC is unreported even in patients with recognized AR (allergic rhinitis). Therefore, the objective of the present study was to identify the incidence of AC in patients with AR.Methods: This randomized observational study was conducted on 110 patients for a 6 month period from February to July 2019, having diagnosed AR and attending the outpatient clinic in CHC Chenani, district Udhampur, Jammu and Kashmir. The patients were directly questioned if they had AC, clarified by using standard screening questions of red, itchy and watery eyes and quantified by TOSS and were asked about indirect symptoms that may be attributable to AC.Results: Among the 110 patients, 50.9% of patients identified AC on direct questioning; additional symptoms were squint at 47.3% and blinking at 51.2%. Olopatadine, significantly reduced TOSS scores within 5 minutes of treatment and 80.9% showed improvement, which identified 39% silent sufferers of AC. A total of 90% AC subjects were identified through TOSS symptoms and totally 95.5%, detecting additional symptoms. The other co-morbidity that was associated with allergic conjunctivitis was allergic dermatitis.Conclusions: The screening questions could identify only about 56% of the patients with AC. Additional specific questioning and a therapeutic challenge in suspected patients can help identify patients who may benefit from treatment of AC. 


Immunotherapy ◽  
2019 ◽  
Vol 11 (16) ◽  
pp. 1387-1397
Author(s):  
Alson Wai-ming Chan ◽  
Wing Pan Luk ◽  
Ling Hiu Fung ◽  
Tak Hong Lee

Aim: We investigated sublingual immunotherapy for mite-induced allergic rhinitis and its comorbid allergic conditions. Patients & methods: A prospective case-controlled study of 120 patients (case = 80, control = 40) over 12 months. Results: There was 53.6% reduction in total rhinitis symptom score (p < 0.0001), but not in controls (-7.3%, p = 0.99). The total symptom scores for concurrent asthma decreased from 17.79 to 8.8 (p < 0.0001); for allergic conjunctivitis from 20.89 to 10.0 (p = 0.0002); for atopic dermatitis from 46.40 to 29.38 (p = 0.0004) and 74.6% of patients weaned off nasal topical steroids. The treatment-related adverse reactions were mild and self-limiting. Conclusion: Though sublingual immunotherapy may be more expensive than conventional treatments, it was an adjunctive therapy that improved not only the outcomes for allergic rhinitis, but also its comorbid allergic conditions.


2014 ◽  
Vol 52 (3) ◽  
pp. 87-92 ◽  
Author(s):  
Ayfer Ulcay Belgu ◽  
Yusuf Orhan Ucal ◽  
Asiye Ekinci ◽  
Meryem Guler Alis ◽  
Omursen Yildirim ◽  
...  

2008 ◽  
Vol 22 (3) ◽  
pp. 183-187 ◽  
Author(s):  
Tong Qiao ◽  
Yizhen Hu ◽  
Zhinan Wang

The Lancet ◽  
1955 ◽  
Vol 265 (6857) ◽  
pp. 234-235 ◽  
Author(s):  
W.S. Foulds ◽  
D.P. Gkeaves ◽  
H. Herxheimer ◽  
L.G. Kingdom

Sign in / Sign up

Export Citation Format

Share Document